Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis
This study has been terminated.
( Inadequate enrollment )
Study NCT00047827.   Last updated on September 29, 2008.
Information provided by Astellas Pharma Inc
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aspergillosis
More general conditions related to this trial
Mycoses
Interventions listed in this trial
Micafungin
Liposomal Amphotericin B
Additional drug interventions recognized in this trial
Abelcet
Amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antifungal
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Astellas Pharma Inc


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services